Sonnet Biotherapeutics 獲股東批准與 Hyperliquid Strategies Inc 進行業務合併
ChainCatcher 消息，据市場消息，納斯達克上市生物科技公司 Sonnet Biotherapeutics 已獲得股東批准，擬與 Hyperliquid Strategies Inc 進行業務合併。
此前消息，Hyperliquid Strategies 提交 S-1 文件，擬募資最高 10 億美元或用於購入 HYPE 代幣。
風險提示 風險提示
BTC $84,856.45 -0.35%
ETH $2,681.23 -0.30%
BNB $779.72 +0.78%
XRP $1.49 -0.96%
SOL $119.69 -0.24%
TRX $0.3372 +0.41%
DOGE $0.0930 -2.03%
ADA $0.2448 -2.91%
BCH $313.26 +0.82%
LINK $13.88 -2.16%
HYPE $88.91 -0.36%
AAVE $178.81 -2.34%
SUI $1.17 +0.17%
XLM $0.2133 -3.49%
ZEC $1,296.48 -5.15%
AAPL $333.31 -0.12%
AMZN $251.71 +0.23%
GOOGL $343.10 -0.34%
MSFT $517.57 +0.58%
META $728.76 -0.29%
NVDA $234.57 -0.35%
TSLA $370.71 -0.50%
SNDK $1,716.37 -0.41%
INTC $118.20 -2.49%
SPCX $159.06 +0.77%
MU $1,070.89 -0.81%
AMD $632.44 +0.27% BTC $84,856.45 -0.35% ETH $2,681.23 -0.30% BNB $779.72 +0.78% XRP $1.49 -0.96% SOL $119.69 -0.24% TRX $0.3372 +0.41% DOGE $0.0930 -2.03% ADA $0.2448 -2.91% BCH $313.26 +0.82% LINK $13.88 -2.16% HYPE $88.91 -0.36% AAVE $178.81 -2.34% SUI $1.17 +0.17% XLM $0.2133 -3.49% ZEC $1,296.48 -5.15% AAPL $333.31 -0.12% AMZN $251.71 +0.23% GOOGL $343.10 -0.34% MSFT $517.57 +0.58% META $728.76 -0.29% NVDA $234.57 -0.35% TSLA $370.71 -0.50% SNDK $1,716.37 -0.41% INTC $118.20 -2.49% SPCX $159.06 +0.77% MU $1,070.89 -0.81% AMD $632.44 +0.27%
風險提示 風險提示
ChainCatcher 與創新者共建Web3世界
